EIDX - Eidos Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Eidos Therapeutics's activity chart (see below) currently has 31 price targets and 24 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 100% of the time, taking 408.13 days on average.

Most recent stock forecast was given by JOEL BEATTY from BAIRD on 29-Dec-2020. First documented stock forecast 27-Aug-2018.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 29-Dec-2020

$129

$73.26

5 years 10 months 24 days ago
(29-Dec-2020)

3/3 (100%)

$129 (0.00%)

66

Buy Since 17-Apr-2019

$56

6 years 4 days ago
(18-Nov-2020)

2/2 (100%)

$56 (0.00%)

533

Buy Since 21-Feb-2019

$73.26

$50

6 years 1 months 16 days ago
(06-Oct-2020)

3/3 (100%)

$73.26 (0.00%)

430

Buy Since 22-Jul-2019

$73.26

$80

6 years 1 months 17 days ago
(05-Oct-2020)

3/3 (100%)

$73.26 (0.00%)

307

Buy Since 30-Oct-2019

$73

$59

6 years 1 months 17 days ago
(05-Oct-2020)

3/3 (100%)

$73 (0.00%)

249

Show more analysts

Please expand the browser size to see the chart

What is EIDX (Eidos Therapeutics) average time for price targets to be met?

On average it took 408 days for the stock forecasts to be reached, with an average price target met ratio of 100%.

Which analyst most recently updated their price target on EIDX (Eidos Therapeutics)?

Joel Beatty

Which analyst has the lowest performance score on EIDX (Eidos Therapeutics) with a proven track record?

ANUPAM RAMA

Which analyst has the most public recommendations on EIDX (Eidos Therapeutics)?

Joel Beatty works at BAIRD and has 6 price targets and 5 ratings on EIDX

Which analyst is the currently most bullish on EIDX (Eidos Therapeutics)?

Joel Beatty with the highest potential upside of $6.79

Which analyst is the currently most reserved on EIDX (Eidos Therapeutics)?

Anupam Rama with the lowest potential downside of -$72.21
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?